Phase 2 Lung Cancer (NSCLC) trials recruiting now

All Lung Cancer (NSCLC) trials, every phase

Other phases for Lung Cancer (NSCLC)

Phase 2 Lung Cancer (NSCLC) trials

• A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
  NCT06228326 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer
  NCT07103395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
  NCT07207395 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• DC/NK Cell Therapy
  NCT07202611 · Phase: Phase 2 · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy
  NCT07213375 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
  NCT07405190 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer
  NCT07379476 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients
  NCT06987734 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）
  NCT06924398 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)
  NCT06784791 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• SL-28 for Advanced Solid Tumours
  NCT07341737 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC
  NCT07120282 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
  NCT07489066 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 27 locations
• TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients
  NCT06455917 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.